Hepatitis C other diagnostic studies
|
Hepatitis C |
|
Diagnosis |
|
Treatment |
|
Hepatitis C other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Hepatitis C other diagnostic studies |
|
Risk calculators and risk factors for Hepatitis C other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Oveerview
Liver Biopsy
Liver biopsy is considered the gold standard for assessing the grade of liver injury (inflammation graded 1 to 4) and stage of liver fibrosis (0 to 4 with the METAVIR score, and 0 to 6 with the Ishak score) prior to the initiation of therapy. With more recent guidelines, although still recommended, liver biopsy is reserved to those patients in which a biopsy would alter the course of treatment.[1] This recommendation takes into consideration that despite being a preferred approach, liver biopsy is invasive and has a significant risk for severe complications. Liver biopsies are also subject to sampling errors.[2]
References
- ↑ Dienstag JL (2002). "The role of liver biopsy in chronic hepatitis C." Hepatology. 36 (5 Suppl 1): S152–60. doi:10.1053/jhep.2002.36381. PMID 12407589.
- ↑ Yee HS, Chang MF, Pocha C, Lim J, Ross D, Morgan TR; et al. (2012). "Update on the management and treatment of hepatitis C virus infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office". Am J Gastroenterol. 107 (5): 669–89, quiz 690. doi:10.1038/ajg.2012.48. PMID 22525303.